Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomas

Original Article

|Open Access
Article Access Statistics
  • Viewed

    1176

  • Downloaded

    20

See Updates
Table of Contents
Cancer Drug Resistance
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.